Page last updated: 2024-08-23

5-benzylacyclouridine and Cancer of Prostate

5-benzylacyclouridine has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calabresi, P; Chen, TM; Chu, E; Chu, MY; Chu, SH; Lipsky, MH; Pan, BC; Yee, LK	1

Other Studies

1 other study(ies) available for 5-benzylacyclouridine and Cancer of Prostate

Article	Year
Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell lines. Pharmacology, 1998, Volume: 56, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fluorouracil; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Thymidylate Synthase; Tumor Cells, Cultured; Uracil; Uridine Phosphorylase	1998

Article

Year

Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell lines.

Pharmacology, 1998, Volume: 56, Issue:2

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fluorouracil; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Thymidylate Synthase; Tumor Cells, Cultured; Uracil; Uridine Phosphorylase

1998